Search

We specialise in fast, de‑risked discovery and optimisation of peptide‑based radiotheranostics. By uniting peptide discovery, structure‑guided optimisation, and end‑to‑end radiopharmaceutical development and imaging, we... Read more

This platform establishes rational design rules for guide RNAs that enable single‑nucleotide–discriminating RNA silencing using CRISPR Cas13b. By exploiting newly mapped mismatch‑intolerant spacer positions, it selectively... Read more

Precision Guided Munition (PGM) CAR T-cells use a tumour‑specific switch to release cytokines only within the tumour microenvironment. This enables potent anti‑tumour activity with near‑zero off‑tumour expression,... Read more

Peter Mac researchers are advancing breakthrough innovations in precision medicine, cellular immunotherapies, radiopharmaceuticals, small‑molecule discovery and liquid biopsy technologies. We offer a diverse portfolio of... Read more